Trost Timothy W. 4
4 · Werewolf Therapeutics, Inc. · Filed Jan 18, 2022
Insider Transaction Report
Form 4
Trost Timothy W.
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2022-01-06+65,960→ 65,960 totalExercise: $11.55Exp: 2032-01-05→ Common Stock (65,960 underlying)
Footnotes (1)
- [F1]The option was granted on January 6, 2022 with a Vesting Commencement Date of January 1, 2022. The shares underlying the option vest over four years, with 25% of the shares vesting on the first anniversary of the Vesting Commencement Date and 2.0833% of the shares vesting each month thereafter through January 1, 2026.